首页>
外国专利>
Use of recombinant ganoderma lucidum immunomodulatory protein (rLZ-8) in preparation of medicine for treating melanoma
Use of recombinant ganoderma lucidum immunomodulatory protein (rLZ-8) in preparation of medicine for treating melanoma
展开▼
机译:重组灵芝免疫调节蛋白(rLZ-8)在制备治疗黑色素瘤的药物中的用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
Disclosed in the present invention is the use of a recombinant Ganoderma lucidum immunomodulatory protein (rLZ-8) in the preparation of a medicine for resisting melanomas. The present invention uses in situ tumour and metastatic tumour experimental animal models to study the anti-tumour effect of rLZ-8, which have indicated that rLZ-8 can significantly inhibit melanoma in situ tumour growth and metastasis lesion formation.
展开▼